# Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

> **NCT00553787** · PHASE3 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 2487 (actual)

## Conditions studied

- Obesity
- Type 2 Diabetes

## Interventions

- **DRUG:** VI-0521
- **DRUG:** VI-0521
- **DRUG:** VI-0521

## Key facts

- **NCT ID:** NCT00553787
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 2487 (ACTUAL)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553787, "Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00553787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*